AI-generated summary
In streptozotocin-induced diabetic mice, the authors compared photobiomodulation alone and combined with metformin or insulin on behavior, tissue histology and gene expression related to neuropathy and cognitive impairment. They report that all treatment groups improved over diabetic controls, with combination groups showing the most pronounced recovery. The study was conducted in mice, so its relevance to human diabetes is uncertain.
- Who or what was studied
- Streptozotocin-induced diabetic mice
- Limits stated in the abstract
- The study was conducted in diabetic mice, and the abstract does not report a sample size or wavelength details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy, Oxidative stress, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.